Skip to content

Advanced Financial Management · Regulatory framework and processes

Competition Regulation and Merger Control for ACCA AFM

Updated 11 October 2026 · Fact-checked

Merger control is the process by which competition authorities review a deal to decide if it would substantially reduce competition or harm the public interest. They can clear it, clear it with remedies, or block it. In AFM, you assess the risk, the likely timetable and cost, and the effect on deal value and strategy.

Understand Competition Regulation and Merger Control

A competition authority exists to protect competition. Competition keeps prices low, quality high and innovation moving. A merger can weaken it, so many countries require large deals to be notified and reviewed before they complete.

The review usually has two stages. In phase 1, the authority does a quick screen. It asks whether the deal could substantially reduce competition. Most deals are cleared here. If concerns remain, the deal moves to phase 2, a detailed investigation. This is often called a referral. Phase 2 is longer, costs far more, and carries a real chance of a block or forced remedies. The exact thresholds, names and timings differ by country, so in the exam use the facts given in the scenario rather than quoting figures from memory.

The type of merger matters. A horizontal merger joins direct competitors. It raises the most concern because market share and pricing power can rise sharply. A vertical merger joins firms at different stages of the supply chain. The worry here is foreclosure: the merged firm might deny rivals supplies or customers. A conglomerate merger joins unrelated businesses. It rarely raises competition concerns.

Some regimes also allow a public interest test. This looks beyond competition to issues such as national security, media plurality, financial stability, jobs or critical infrastructure. Governments may intervene on these grounds even when competition is not harmed.

For an AFM adviser, the point is strategy and value. Regulatory risk affects the timetable, the cost of delay, the synergies that survive, and the price a bidder should offer. If the authority demands remedies, such as selling a division, the deal value falls. You should be able to say what could be done: seek early engagement with the authority, offer remedies upfront, include a break fee or a condition in the offer, or choose a different structure such as a joint venture or alliance.

Key rules to remember

Expected value of a deal under regulatory risk
Expected value = (P(clear) × value if cleared) + (P(remedies) × value after remedies) + (P(block) × value if blocked)
Probabilities must add up to 1. Use this when the question gives probabilities for outcomes.
Value of synergies after remedies
Net synergy value = PV of synergies − PV of lost cash flows from divested units − costs of delay and regulatory process
Remedies reduce the benefits of the deal. Show the deduction clearly.
Cost of delay
Cost of delay = annual synergy benefit lost per year × years of delay (discounted if time is material)
Delay also pushes synergies later, which lowers their present value.
Merger types and main concern
Horizontal = competitors (market power); Vertical = supply chain (foreclosure); Conglomerate = unrelated (little concern)
Link the type of merger to the concern in every answer.

How to solve Competition Regulation and Merger Control questions

Use this method for any question on merger control, whether it is discussion, calculation or both.

  1. 1Identify the type of merger: horizontal, vertical or conglomerate. State it in one line.
  2. 2Describe the markets involved and combined market share or power, using only the facts given.
  3. 3Say which authority is likely to review the deal and whether a phase 1 clearance or phase 2 referral is likely, with the reason.
  4. 4Consider any public interest issues in the scenario, such as jobs, national security or critical infrastructure.
  5. 5List the possible outcomes: clearance, clearance with remedies, or block. Give their effect on timetable, cost and synergies.
  6. 6Quantify where the data allows. Use expected values or deduct divestment losses and delay costs from the deal value.
  7. 7Recommend a strategy: early engagement, offered remedies, deal conditions, a revised price, or an alternative such as a JV.
  8. 8Finish with a clear conclusion that answers the requirement and uses the scenario.

Quickest way: Four-line regulatory risk check

When to use it: Use when time is short, or when the requirement is a short discussion of regulatory issues in a bid.

  1. Type: horizontal, vertical or conglomerate, and why that matters.
  2. Risk: low, medium or high chance of phase 2, based on market share and rivals.
  3. Impact: delay, cost, remedies and lost synergies, with numbers if given.
  4. Action: engage early, offer remedies, add conditions, adjust price or restructure.

Common mistakes in Competition Regulation and Merger Control

  • Treating all mergers as equally risky for competition.

    Students recall the general rule and skip the type of merger.

    Fix: State the type first. Horizontal deals carry the most risk; conglomerate deals the least.

  • Quoting specific market share thresholds or deadlines from memory.

    Students try to show detailed knowledge, but rules differ by country and change over time.

    Fix: Use the figures in the scenario. Describe the process in general terms.

  • Confusing phase 1 and phase 2.

    Both are called reviews and the names sound similar.

    Fix: Phase 1 is a quick screen. Phase 2 is the detailed investigation with a higher chance of remedies or a block.

  • Ignoring the effect on deal value.

    Students write about law and forget AFM is a finance paper.

    Fix: Link every regulatory point to cost, time, synergies, price or risk.

  • Mixing up public interest with competition grounds.

    Both can lead to intervention, so they seem the same.

    Fix: Competition looks at market power. Public interest looks at wider issues such as security, jobs or stability. Say which applies.

  • Giving a list of points with no application or recommendation.

    Students run out of time or treat it as a knowledge question.

    Fix: Tie each point to the scenario and end with advice. This also earns professional skills marks.

Worked examples

Example 1

Alpha plc plans to buy Beta plc, a direct competitor. Together they would hold a large share of the national market. Alpha expects synergies with a present value of ₹400 crore. Advisers estimate: 50% chance of clearance at phase 1 (synergy value ₹400 crore), 30% chance of clearance after phase 2 with remedies (net synergy value ₹250 crore), and 20% chance of the deal being blocked (value nil). Calculate the expected value of synergies and comment.

Show the solution
  1. Identify the merger: horizontal, so the risk of a phase 2 referral is high.
  2. Check probabilities: 0.5 + 0.3 + 0.2 = 1.0.
  3. Phase 1 clearance: 0.5 × ₹400 crore = ₹200 crore.
  4. Remedies outcome: 0.3 × ₹250 crore = ₹75 crore.
  5. Block: 0.2 × 0 = ₹0.
  6. Expected value = 200 + 75 + 0 = ₹275 crore.
  7. Comment: expected synergies are ₹125 crore below the headline figure of ₹400 crore (400 − 275).

Answer: Expected value of synergies is ₹275 crore. Alpha should not pay for the full ₹400 crore of synergies. It should consider offering remedies early, adding a regulatory condition to the offer, and negotiating a price that reflects the risk.

Example 2

Gamma Ltd, a manufacturer, wants to buy Delta Ltd, its main supplier of a key component. Rival manufacturers rely on Delta. Explain the competition concerns, and advise Gamma on how regulatory risk could affect its strategy.

Show the solution
  1. Identify the type: vertical, because the firms are at different stages of the supply chain.
  2. Explain the concern: foreclosure. Gamma could refuse to supply rivals or raise their prices, reducing competition downstream.
  3. Assess likelihood: because rivals depend on Delta, a phase 2 referral is a real possibility.
  4. Explain the impact: longer timetable, higher costs, uncertain synergies, and possible remedies.
  5. Possible remedies: commit to supply rivals on fair terms, or keep Delta operating separately in some respects.
  6. Strategy: engage the authority early, offer behavioural commitments, add a regulatory clearance condition to the deal, and consider a long-term supply contract or a JV as an alternative.
  7. Conclude: proceed only if the benefits still justify the price after allowing for delay, remedies and the chance of a block.

Answer: The deal is a vertical merger with a foreclosure risk. A phase 2 review is plausible. Gamma should engage early, offer supply commitments, make the deal conditional on clearance, and test the value of the deal after remedies and delay. A supply contract or JV may deliver much of the benefit with less regulatory risk.

Exam tips

  • Name the merger type in your first sentence. It anchors the rest of the answer.
  • Use only the market data in the scenario. Do not invent shares, thresholds or deadlines.
  • Always link regulation to value: delay, remedies, lost synergies, price and conditions in the offer.
  • End with a recommendation. In AFM the professional skills marks reward clear, practical advice for the board.
  • If the question gives probabilities, calculate an expected value and then comment on what it means for the offer price.

Practice questions from Regulatory framework and processes

Competition Regulation and Merger Control: frequently asked questions

What is a phase 2 merger referral?

It is the detailed investigation a competition authority opens when a quick phase 1 screen finds concerns about reduced competition. It takes longer and costs more. The deal may be cleared, cleared with remedies, or blocked.

What is the difference between horizontal and vertical merger regulation?

Horizontal mergers join competitors, so authorities focus on market share and pricing power. Vertical mergers join firms in the same supply chain, so the focus is on foreclosure of rivals from supplies or customers.

What is a public interest test?

It is a review of a deal on grounds beyond competition, such as national security, jobs, media plurality or financial stability. Not every regime has one, and it varies by country.

Do I need to know exact thresholds and timelines for AFM?

No. AFM tests how regulatory risk affects strategy and value. Use the figures in the scenario and explain the process in general terms.